MILFORD, Mass.--(BUSINESS WIRE)--SeraCare Life Sciences, Inc. (SRLS:PK), a biopharmaceutical company providing vital products and services to the global life sciences industry to facilitate the discovery, development and production of human and animal diagnostics and therapeutics, today announced the appointment of Michael K. Steele as Vice President of Business Development. In this position, Mr. Steele will work with SeraCare’s leadership team to identify and execute strategic alliances and transactions to broaden SeraCare’s product portfolio in the diagnostic and biopharmaceutical marketplace. Mr. Steele will report directly to Susan Vogt, President and Chief Executive Officer.